{
  "meta": {
    "title": "Cirrhosis_Portal_Hypertension",
    "url": "https://brainandscalpel.vercel.app/cirrhosis-portal-hypertension-cf79ec0a.html",
    "scrapedAt": "2025-11-29T18:24:49.918Z"
  },
  "questions": [
    {
      "id": 10483,
      "choices": [
        {
          "id": 41898,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Immediate initiation of oral beta-blockers</span></span></span></p>"
        },
        {
          "id": 41899,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Administer a course of oral antibiotics</span></span></span></p>"
        },
        {
          "id": 41900,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Repeat endoscopic ligation in 24 hours</span></span></span></p>"
        },
        {
          "id": 41901,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Schedule for a transjugular intrahepatic portosystemic shunt (TIPS)</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 45-year-old woman with alcohol use disorder undergoes successful endoscopic variceal ligation after variceal hemorrhage. To reduce rebleeding risk, the most appropriate additional treatment is : </span></span></p>",
      "unique_key": "Q1586234",
      "question_audio": null,
      "question_video": null,
      "map_id": 30772,
      "difficulty_level": "difficult",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. B) Administer a course of oral antibiotics (kindly check answer ????)</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><strong><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Option B: </span></span></span></strong></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Antibiotic prophylaxis, typically with a broad-spectrum antibiotic such as ceftriaxone or a fluoroquinolone, is recommended in patients with cirrhosis who have had a gastrointestinal bleed to reduce the risk of bacterial infections, which are common after such events, and to decrease the incidence of recurrent bleeding.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Immediate initiation of oral beta-blockers</span></strong><span style=\"font-size:12.0pt\">: While beta-blockers are important in the secondary prophylaxis of variceal bleeding, their immediate initiation is not as crucial as antibiotic prophylaxis.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Repeat endoscopic ligation in 24 hours:</span></strong><span style=\"font-size:12.0pt\"> Repeat endoscopic ligation is not typically performed within 24 hours unless there is evidence of rebleeding.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Schedule for a transjugular intrahepatic portosystemic shunt (TIPS):</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">TIPS is reserved for patients who fail medical and endoscopic therapy and is not used as immediate prophylaxis after the first variceal bleed.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Antibiotic prophylaxis helps in preventing rebleeding and infections after an initial variceal hemorrhage.</span></span></span></p>",
      "correct_choice_id": 41899,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 20255,
      "choices": [
        {
          "id": 80981,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Jaundice</span></span></span></p>"
        },
        {
          "id": 80982,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Easy bruising</span></span></span></p>"
        },
        {
          "id": 80983,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Spider nevi</span></span></span></p>"
        },
        {
          "id": 80984,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Caput medusae</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following clinical features is most indicative of advanced cirrhosis with portal hypertension?</span></span></p>",
      "unique_key": "Q2754825",
      "question_audio": null,
      "question_video": null,
      "map_id": 30748,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. D) Caput medusae </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Caput medusae, the appearance of distended and engorged paraumbilical veins, is a hallmark sign of portal hypertension, a common complication of advanced cirrhosis. This feature indicates the development of collateral venous circulation as a result of increased pressure in the portal venous system.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/20/screenshot-2024-08-20-140329.png\" style=\"height:278px; width:300px\" />.</p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation:</span></u></strong><u> </u></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Jaundice:</span></strong><span style=\"font-size:12.0pt\">&nbsp; Jaundice is a sign of liver dysfunction but is not specific to portal hypertension.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Easy bruising:</span></strong><span style=\"font-size:12.0pt\"> Easy bruising can indicate liver dysfunction due to decreased production of clotting factors but, like jaundice, is not specific to portal hypertension.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Spider nevi:</span></strong><span style=\"font-size:12.0pt\"> Spider nevi are associated with liver disease but are less specific for portal hypertension compared to caput medusae.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational Objective:</span></u></strong><u> </u></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Caput medusae is a clinical feature indicative of portal hypertension in the setting of advanced cirrhosis.</span></span></span></p>",
      "correct_choice_id": 80984,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 20291,
      "choices": [
        {
          "id": 81125,
          "text": "<p><span style=\"font-size:12.0pt;\">Acute stroke</span></p>"
        },
        {
          "id": 81126,
          "text": "<p><span style=\"font-size:12.0pt;\">Hepatic encephalopathy</span></p>"
        },
        {
          "id": 81127,
          "text": "<p><span style=\"font-size:12.0pt;\">Alzheimer's disease</span></p>"
        },
        {
          "id": 81128,
          "text": "<p><span style=\"font-size:12.0pt;\">Normal pressure hydrocephalus</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 62-year-old man with a history of cirrhosis due to chronic hepatitis B infection presents with altered mental status. On examination, he exhibits asterixis. Which of the following best describes this patient's condition?</span></p>",
      "unique_key": "Q4966915",
      "question_audio": null,
      "question_video": null,
      "map_id": 30763,
      "difficulty_level": "difficult",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Hepatic encephalopathy</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The presentation of altered mental status, increasing confusion, difficulty performing simple tasks, and the presence of asterixis (a flapping tremor of the hands when the wrists are extended) in a patient with a history of cirrhosis due to chronic hepatitis B infection is most consistent with hepatic encephalopathy. Hepatic encephalopathy is a neuropsychiatric syndrome caused by liver dysfunction and the inability to detoxify substances, leading to the accumulation of toxins such as ammonia, which affects brain function.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong><u>Explanation:</u></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Acute stroke:</strong> Typically presents with sudden onset neurological deficits such as weakness or numbness on one side of the body, difficulty speaking, or facial drooping, which are not described in this case.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Alzheimer's disease:</strong> Is a progressive neurodegenerative disorder characterized by gradual memory loss, cognitive decline, and changes in behavior, but it does not typically present with acute changes or asterixis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Normal pressure hydrocephalus:</strong> Is characterized by the triad of gait disturbance, urinary incontinence, and cognitive decline, but the acute onset and presence of asterixis are more indicative of hepatic encephalopathy in the context of known liver disease.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong><u>Educational Objective:</u></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Hepatic encephalopathy's characteristic presentation in a patient with underlying liver disease, includes altered mental status, confusion, difficulty with tasks, and asterixis, which highlights liver function in neuropsychiatric status.</span></p>",
      "correct_choice_id": 81126,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "InvestigationBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 20275,
      "choices": [
        {
          "id": 81061,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Serum albumin level</span></span></span></p>"
        },
        {
          "id": 81062,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">International normalized ratio (INR)</span></span></span></p>"
        },
        {
          "id": 81063,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Serum sodium level</span></span></span></p>"
        },
        {
          "id": 81064,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Ascites</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following parameters is NOT included in the Child-Turcotte-Pugh (CTP) score to assess the severity of liver disease?</span></span></p>",
      "unique_key": "Q5557465",
      "question_audio": null,
      "question_video": null,
      "map_id": 30750,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. C) Serum sodium level</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The CTP score assesses the severity of liver cirrhosis using five clinical and laboratory parameters: serum bilirubin, serum albumin, INR, ascites, and hepatic encephalopathy. Serum sodium level is not included in the CTP score but is considered in the Model for End-Stage Liver Disease (MELD) score.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation: </span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Serum albumin level:</span></strong><span style=\"font-size:12.0pt\"> Is included in the CTP score as a measure of the liver&#39;s synthetic function.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. International normalized ratio:</span></strong><span style=\"font-size:12.0pt\"> INR is included to assess the liver&#39;s ability to synthesize clotting factors.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Ascites:</span></strong><span style=\"font-size:12.0pt\"> The presence and severity of ascites are used to evaluate the liver&#39;s synthetic function and portal hypertension.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational Objective:</span></u></strong><u> </u></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">To recognize the components of the Child-Turcotte-Pugh score and understand that serum sodium level is not included in this assessment of liver disease severity.</span></span></span></p>",
      "correct_choice_id": 81063,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "CriteriaBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 20277,
      "choices": [
        {
          "id": 81069,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Child-Pugh class A</span></span></span></p>"
        },
        {
          "id": 81070,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Child-Pugh class B</span></span></span></p>"
        },
        {
          "id": 81071,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Child-Pugh class C</span></span></span></p>"
        },
        {
          "id": 81072,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Child-Pugh class D</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A patient with chronic liver disease has a Child-Pugh score of 8. Which Child-Pugh class does this score fall into?</span></span></p>",
      "unique_key": "Q9300606",
      "question_audio": null,
      "question_video": null,
      "map_id": 30751,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. </span></strong><strong><span style=\"font-size:12.0pt\">B) Child-Pugh class B</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The Child-Pugh score is used to assess the prognosis of chronic liver disease and cirrhosis. It categorizes patients into three classes based on their score: Class A (5-6 points) indicates the least severe disease, Class B (7-9 points) indicates moderate disease severity, and Class C (10-15 points) indicates severe disease. A score of 8 falls into Class B, indicating moderate severity of liver disease.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">&nbsp;<u>Explanation: </u></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Child-Pugh class A:</span></strong><span style=\"font-size:12.0pt\"> Is for scores of 5-6, representing mild liver disease.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C.&nbsp; Child-Pugh class C:</span></strong><span style=\"font-size:12.0pt\"> Is for scores of 10-15, representing severe liver disease.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D.</span></strong><span style=\"font-size:12.0pt\"> <strong>Child-Pugh class D: </strong>There is no Child-Pugh class D in the classification system.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational Objective:</span></u></strong><u> </u></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Child-Pugh score of 8 categorizes a patient with chronic liver disease into Class B, indicating moderate severity.</span></span></span></p>",
      "correct_choice_id": 81070,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "CriteriaBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 20284,
      "choices": [
        {
          "id": 81097,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Oral spironolactone</span></span></span></p>"
        },
        {
          "id": 81098,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Intravenous albumin</span></span></span></p>"
        },
        {
          "id": 81099,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Oral antibiotics</span></span></span></p>"
        },
        {
          "id": 81100,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Nonselective beta-blockers</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following is the most appropriate pharmacological treatment to add for persistent ascites in cirrhotic patients after dietary sodium restriction ?</span></span></p>",
      "unique_key": "Q1208639",
      "question_audio": null,
      "question_video": null,
      "map_id": 30757,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. A) Oral spironolactone</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Oral spironolactone, a potassium-sparing diuretic, is the first-line pharmacological treatment for persistent ascites in cirrhotic patients after dietary sodium restriction. It works by antagonizing aldosterone, reducing sodium and water retention.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Explanation:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Intravenous albumin:</span></strong><span style=\"font-size:12.0pt\">&nbsp; Intravenous albumin is used primarily in the management of large-volume paracentesis or in specific cases like spontaneous bacterial peritonitis, not as a first-line treatment for moderate ascites.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Oral antibiotics:</span></strong><span style=\"font-size:12.0pt\"> Oral antibiotics are used for the treatment or prevention of spontaneous bacterial peritonitis, not for the direct management of ascites.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Nonselective beta-blockers:</span></strong><span style=\"font-size:12.0pt\"> Nonselective beta-blockers are used for variceal bleeding prophylaxis and can worsen ascites in some cirrhotic patients by reducing renal perfusion.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational Objective</span></u></strong><strong><span style=\"font-size:12.0pt\">:</span></strong> </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Oral spironolactone is the first-line pharmacological treatment for cirrhotic patients with persistent ascites despite dietary sodium restriction.</span></span></span></p>",
      "correct_choice_id": 81097,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "CriteriaBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 20285,
      "choices": [
        {
          "id": 81101,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Oral proton pump inhibitors</span></span></span></p>"
        },
        {
          "id": 81102,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Endoscopic band ligation</span></span></span></p>"
        },
        {
          "id": 81103,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Intravenous octreotide</span></span></span></p>"
        },
        {
          "id": 81104,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Immediate liver transplantation</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">A 47-year-old male with known cirrhosis presents to the emergency department with hematemesis. He is hypotensive and tachycardic. After initial resuscitation with IV fluids, what is the most appropriate next step in the management of suspected variceal bleeding?</span></span></span></p>",
      "unique_key": "Q1467177",
      "question_audio": null,
      "question_video": null,
      "map_id": 30758,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. C) Intravenous octreotide</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Intravenous octreotide is part of the initial management of acute variceal bleeding as it helps reduce portal vein pressure, decreasing the risk of further hemorrhage. It should be initiated as soon as variceal bleeding is suspected, even before endoscopic confirmation.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Oral proton pump inhibitors:</span></strong><span style=\"font-size:12.0pt\"> Oral proton pump inhibitors are used in the management of peptic ulcer disease bleeding, not variceal bleeding.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Endoscopic band ligation:</span></strong><span style=\"font-size:12.0pt\"> Endoscopic band ligation is a definitive treatment for variceal bleeding but may not be immediately available and should be preceded by pharmacological therapy to control the bleeding.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Immediate liver transplantation:</span></strong><span style=\"font-size:12.0pt\"> Immediate liver transplantation is not a practical immediate step in the acute management of variceal bleeding.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational Objective:</span></u></strong><u> </u></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Intravenous octreotide is a critical component of the initial management of acute variceal bleeding in cirrhotic patients.</span></span></span></p>",
      "correct_choice_id": 81103,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 20286,
      "choices": [
        {
          "id": 81105,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Child-Pugh class A</span></span></span></p>"
        },
        {
          "id": 81106,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Child-Pugh class B</span></span></span></p>"
        },
        {
          "id": 81107,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Child-Pugh class C</span></span></span></p>"
        },
        {
          "id": 81108,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Child-Pugh class D</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Child-Pugh score of 8 comes under ?</span></span></p>",
      "unique_key": "Q3876863",
      "question_audio": null,
      "question_video": null,
      "map_id": 30759,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. B. Child-Pugh class B</span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The Child-Pugh score is calculated by adding the scores for the five factors and can range from 5 to 15. The resulting Child-Pugh class can be A (a score of 5&ndash;6), B (7&ndash;9), or C (&ge;10). Decompensation indicates cirrhosis, with a Child-Pugh score of &ge;7 (class B).</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ref: Harrison&rsquo;s 21<sup>st</sup> edition page no 2552</span></strong></span></span></p>",
      "correct_choice_id": 81106,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 20287,
      "choices": [
        {
          "id": 81109,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Arterial blood gas analysis </span></span></span></p>"
        },
        {
          "id": 81110,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Pulmonary function tests </span></span></span></p>"
        },
        {
          "id": 81111,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Computed tomography pulmonary angiography (CTPA) </span></span></span></p>"
        },
        {
          "id": 81112,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Transthoracic echocardiogram</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 68-year-old man who recently underwent total knee replacement surgery presents with sudden onset of shortness of breath and pleuritic chest pain. His ECG shows sinus tachycardia and the D-dimer test is elevated. Which of the following is the most appropriate next step in diagnosing this patient? </span></span></p>",
      "unique_key": "Q1860117",
      "question_audio": null,
      "question_video": null,
      "map_id": 30760,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. </span></strong><strong><span style=\"font-size:12.0pt\">C) Computed tomography pulmonary angiography (CTPA)</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">In a patient with sudden onset of shortness of breath, pleuritic chest pain, a recent history of major surgery (increasing the risk for venous thromboembolism), and an elevated D-dimer test, the most appropriate next step to diagnose or rule out pulmonary embolism (PE) is computed tomography pulmonary angiography (CTPA). CTPA is the gold-standard imaging test for diagnosing PE and can directly visualize clots in the pulmonary arteries.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Arterial blood gas analysis:</span></strong><span style=\"font-size:12.0pt\">&nbsp; Arterial blood gas analysis can show hypoxemia and hypocapnia in the case of PE, but these findings are nonspecific and cannot confirm the diagnosis.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Pulmonary function tests:</span></strong><span style=\"font-size:12.0pt\"> Pulmonary function tests are not useful in the acute setting of suspected PE as they are primarily used to evaluate chronic respiratory conditions.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Transthoracic Echocardiogram:&nbsp; </span></strong><span style=\"font-size:12.0pt\">A transthoracic echocardiogram can be helpful in assessing right ventricular function in the setting of PE and may show signs of right heart strain, but it cannot diagnose PE directly. It is more useful in risk stratification and management rather than initial diagnosis.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The computed tomography pulmonary angiography (CTPA) is the most appropriate diagnostic test for a patient with suspected pulmonary embolism, especially in the context of recent surgery and elevated D-dimer levels.</span></span></span></p>",
      "correct_choice_id": 81111,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 20288,
      "choices": [
        {
          "id": 81113,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Start systemic corticosteroids </span></span></span></p>"
        },
        {
          "id": 81114,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Prescribe a long-acting muscarinic antagonist </span></span></span></p>"
        },
        {
          "id": 81115,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Initiate antibiotic therapy </span></span></span></p>"
        },
        {
          "id": 81116,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Increase the dose of the short-acting bronchodilator</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 72-year-old woman with a history of chronic obstructive pulmonary disease (COPD) presents to the clinic with increased shortness of breath, wheezing, and productive cough for the past 2 days. She uses a short-acting bronchodilator as needed. Which of the following is the most appropriate initial treatment? </span></span></p>",
      "unique_key": "Q8535194",
      "question_audio": null,
      "question_video": null,
      "map_id": 30761,
      "difficulty_level": "difficult",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. </span></strong><strong><span style=\"font-size:12.0pt\">A) Start systemic corticosteroids</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">In a patient with COPD presenting with an acute exacerbation characterized by increased shortness of breath, wheezing, and a change in sputum production or color, the initiation of systemic corticosteroids is an appropriate initial treatment. Corticosteroids help to reduce airway inflammation and improve symptoms in acute exacerbations of COPD.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">&nbsp;<u>Explanation:</u></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Prescribing a long-acting muscarinic antagonist:</span></strong><span style=\"font-size:12.0pt\"> Prescribing a long-acting muscarinic antagonist (LAMA) is a good option for long-term management of COPD to improve symptoms and reduce exacerbations, but it is not the first choice for treating an acute exacerbation.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Initiate antibiotic therapy:</span></strong><span style=\"font-size:12.0pt\"> Antibiotic therapy may be indicated if there is a strong suspicion or evidence of a bacterial infection contributing to the exacerbation, such as increased sputum purulence, but it is not the standard initial treatment for all acute COPD exacerbations.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Increase the dose of the short-acting bronchodilator:</span></strong><span style=\"font-size:12.0pt\">&nbsp; Increasing the dose of a short-acting bronchodilator can provide symptomatic relief and is often part of the management of acute exacerbations, but it may not be sufficient on its own without addressing the inflammation with corticosteroids.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Systemic corticosteroids are an appropriate initial treatment for an acute exacerbation of COPD, as they address the underlying airway inflammation and can improve symptoms and lung function.</span></span></span></p>",
      "correct_choice_id": 81113,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 20289,
      "choices": [
        {
          "id": 81117,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Hemothorax</span></span></span></p>"
        },
        {
          "id": 81118,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Rib fracture</span></span></span></p>"
        },
        {
          "id": 81119,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Tension pneumothorax</span></span></span></p>"
        },
        {
          "id": 81120,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Pulmonary contusion</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 34-year-old man is brought to the emergency department after a motor vehicle accident. He is tachypneic, hypotensive, and has decreased breath sounds on the left side with tracheal deviation to the right. What is the most likely diagnosis?</span></span></p>",
      "unique_key": "Q4789435",
      "question_audio": null,
      "question_video": null,
      "map_id": 30762,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. C) Tension pneumothorax</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The presentation of tachypnea, hypotension, decreased breath sounds on one side, and tracheal deviation to the opposite side is classic for a tension pneumothorax. In this condition, air enters the pleural space and cannot escape, leading to increased intrathoracic pressure, compression of the lung on the affected side, and shifting of the mediastinal structures, including the trachea, to the opposite side. It is a life-threatening emergency requiring immediate intervention.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><u><span style=\"font-size:12.0pt\">&nbsp;<strong>Explanation:</strong></span></u></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Hemothorax:</span></strong><span style=\"font-size:12.0pt\"> Hemothorax involves the accumulation of blood in the pleural space and can present with similar symptoms, but tracheal deviation is more specifically associated with tension pneumothorax due to the significant shift in mediastinal structures.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Rib fractures:</span></strong><span style=\"font-size:12.0pt\"> Rib fractures can cause pain and lead to shallow breathing, potentially causing or contributing to a pneumothorax, but the clinical presentation described is more consistent with a tension pneumothorax.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Pulmonary contusion:</span></strong><span style=\"font-size:12.0pt\"> Pulmonary contusion involves injury to the lung tissue itself and can lead to respiratory distress, but it does not cause tracheal deviation.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The clinical presentation of a tension pneumothorax, includes tachypnea, hypotension, decreased breath sounds on the affected side, and contralateral tracheal deviation, as a life-threatening condition that requires immediate intervention.</span></span></span></p>",
      "correct_choice_id": 81119,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 10481,
      "choices": [
        {
          "id": 41890,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\">Abdominal ultrasound </span></span></span></p>"
        },
        {
          "id": 41891,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\">Esophagogastroduodenoscopy (EGD) </span></span></span></p>"
        },
        {
          "id": 41892,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Contrast-enhanced CT scan of the abdomen </span></span></span></p>"
        },
        {
          "id": 41893,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Barium swallow study</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In a 52-year-old man with a history of alcohol abuse presenting with hematemesis, jaundice, ascites, palmar erythema, spider angiomata, thrombocytopenia, and prolonged PT/INR, what is the most appropriate diagnostic procedure to identify the bleeding source?</span></span></p>",
      "unique_key": "Q1401154",
      "question_audio": null,
      "question_video": null,
      "map_id": 30770,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. B) Esophagogastroduodenoscopy (EGD)</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Esophagogastroduodenoscopy (EGD) is the most immediate next step for diagnosing variceal bleeding, which is a life-threatening complication of portal hypertension often seen in patients with cirrhosis. EGD allows direct visualization of the esophagus, stomach, and duodenum, enabling the physician to identify the source of bleeding and potentially treat it with band ligation or sclerotherapy </span></span></span><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">during the same procedure.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">&nbsp;Explanation:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Abdominal ultrasound:</span></strong><span style=\"font-size:12.0pt\"> Abdominal ultrasound is useful for evaluating the liver, spleen, and portal vein, which could help in assessing the chronic liver disease but is not the immediate test for active upper gastrointestinal bleeding.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Contrast-enhanced CT scan of the abdomen:</span></strong><span style=\"font-size:12.0pt\"> Contrast-enhanced CT scan of the abdomen is helpful in the evaluation of abdominal structures and can provide information about the liver and spleen, but it is not the first-line diagnostic tool for an active variceal bleed.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Barium swallow study: </span></strong><span style=\"font-size:12.0pt\">A barium swallow study may be used to evaluate structural abnormalities of the esophagus and stomach, but it is contraindicated in the setting of an active bleed as it can interfere with endoscopic therapeutic procedures.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational Objective:</span></u></strong><u> </u></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">EGD is the immediate and most appropriate next step in the diagnosis and potential treatment of variceal bleeding in a patient with signs of portal hypertension and cirrhosis.</span></span></span></p>",
      "correct_choice_id": 41891,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 10482,
      "choices": [
        {
          "id": 41894,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Oral propranolol </span></span></span></p>"
        },
        {
          "id": 41895,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Intravenous octreotide </span></span></span></p>"
        },
        {
          "id": 41896,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Intravenous ceftriaxone </span></span></span></p>"
        },
        {
          "id": 41897,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Oral omeprazole</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">For a 50-year-old male with cirrhosis due to hepatitis C presenting with acute hematemesis, jaundice, ascites, and palmar erythema, who has been stabilized with IV fluids, the best immediate pharmacotherapy is:</span></span></p>",
      "unique_key": "Q3340101",
      "question_audio": null,
      "question_video": null,
      "map_id": 30771,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. B) Intravenous octreotide</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Intravenous octreotide is part of the initial management of variceal bleeding as it helps to reduce portal venous pressure by vasoconstriction of the splanchnic circulation. It should be started as soon as variceal bleeding is suspected even before endoscopy.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Oral propranolol: </span></strong><span style=\"font-size:12.0pt\">&nbsp;Is used in the primary prevention of variceal bleeding, not in the acute setting.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Intravenous ceftriaxone: </span></strong><span style=\"font-size:12.0pt\">&nbsp;Is indicated for infection prophylaxis in cirrhotic patients with gastrointestinal bleeding, but it is not the primary treatment for the bleed itself.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Oral omeprazole: </span></strong><span style=\"font-size:12.0pt\">&nbsp;Is a proton pump inhibitor that may help with peptic ulcers but is not the first-line treatment for acute variceal bleeding.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational Objective:</span></u></strong><u> </u></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Intravenous octreotide is the initial pharmacological treatment in the acute management of variceal bleeding.</span></span></span></p>",
      "correct_choice_id": 41895,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 10484,
      "choices": [
        {
          "id": 41902,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Start a proton pump inhibitor (PPI) infusion</span></span></span></p>"
        },
        {
          "id": 41903,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Arrange for an urgent repeat endoscop</span></span></span></p>"
        },
        {
          "id": 41904,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Perform a tagged red blood cell scan</span></span></span></p>"
        },
        {
          "id": 41905,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Prepare for emergent transjugular intrahepatic portosystemic shunt (TIPS) procedure</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">A 56-year-old man with cirrhosis is admitted to the hospital with a variceal bleed. He has been resuscitated and received octreotide and endoscopic band ligation. The next day, he develops melena. His hemoglobin has dropped from 8.5 g/dL on admission to 7.8 g/dL. What is the most appropriate next step in management?</span></span></span></p>",
      "unique_key": "Q7208281",
      "question_audio": null,
      "question_video": null,
      "map_id": 30773,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. B) Arrange for an urgent repeat endoscopy</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B: </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The recurrence of melena and the drop in hemoglobin suggest ongoing upper gastrointestinal bleeding. In this setting, an urgent repeat endoscopy is indicated to reassess the varices, identify the source of the bleed, and perform further therapeutic intervention if necessary.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">&nbsp;Explanation:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Start a proton pump inhibitor (PPI) infusion:</span></strong><span style=\"font-size:12.0pt\">&nbsp; Proton pump inhibitor (PPI) infusion is adjunctive therapy for peptic ulcer disease but would not be the most appropriate next step for suspected ongoing variceal bleeding.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Perform a tagged red blood cell scan</span></strong><span style=\"font-size:12.0pt\">: A tagged red blood cell scan is a diagnostic procedure to localize sites of slow gastrointestinal bleeding but is not appropriate for acute rebleeding where endoscopy is indicated.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Prepare for emergent transjugular intrahepatic portosystemic shunt (TIPS) procedure:&nbsp; </span></strong><span style=\"font-size:12.0pt\">A transjugular intrahepatic portosystemic shunt (TIPS) is considered if endoscopic treatment fails or is not possible; it is not the immediate next step after a drop in hemoglobin without first reassessing endoscopically.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">An urgent repeat endoscopy is indicated in a patient with cirrhosis who develops signs of ongoing variceal bleeding post-initial endoscopic treatment.</span></span></span></p>",
      "correct_choice_id": 41903,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "CriteriaBased",
        "InvestigationBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 20259,
      "choices": [
        {
          "id": 80997,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Abdominal ultrasound</span></span></p>"
        },
        {
          "id": 80998,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Liver biopsy</span></span></p>"
        },
        {
          "id": 80999,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Serum albumin level</span></span></p>"
        },
        {
          "id": 81000,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Upper gastrointestinal endoscopy</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following is the most appropriate diagnostic test to confirm cirrhosis in a patient?</span></span></p>",
      "unique_key": "Q8470866",
      "question_audio": null,
      "question_video": null,
      "map_id": 30749,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. B) Liver biopsy</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Abdominal ultrasound</span></span><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">A liver biopsy is considered the gold standard for diagnosing cirrhosis by allowing histological examination of the liver tissue to assess the extent of fibrosis and architectural disruption. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Abdominal ultrasound:</span></strong><span style=\"font-size:12.0pt\"> Can suggest cirrhosis by showing a nodular liver surface, ascites, or signs of portal hypertension but cannot definitively diagnose cirrhosis.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Serum albumin level:</span></strong><span style=\"font-size:12.0pt\"> Can indicate liver function but is not a diagnostic test for cirrhosis.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Upper gastrointestinal endoscopy:</span></strong><span style=\"font-size:12.0pt\"> Is useful for identifying complications of portal hypertension such as esophageal varices, not for diagnosing cirrhosis itself.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational Objective:</span></u></strong><u> </u></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Liver biopsy is the gold standard diagnostic test for confirming cirrhosis.</span></span></span></p>",
      "correct_choice_id": 80998,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 20278,
      "choices": [
        {
          "id": 81073,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Serum albumin level</span></span></span></p>"
        },
        {
          "id": 81074,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Serum sodium level</span></span></span></p>"
        },
        {
          "id": 81075,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Platelet count</span></span></span></p>"
        },
        {
          "id": 81076,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Hemoglobin level</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 57-year-old woman with end-stage liver disease is being evaluated for liver transplantation. Her recent laboratory tests include serum bilirubin, serum creatinine, and INR. Which additional parameter is essential to calculate her Model for End-Stage Liver Disease (MELD) score?</span></span></p>",
      "unique_key": "Q3490205",
      "question_audio": null,
      "question_video": null,
      "map_id": 30752,
      "difficulty_level": "difficult",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. B) Serum sodium level</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B: </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The Model for End-Stage Liver Disease (MELD) score is calculated using serum bilirubin, serum creatinine, INR, and serum sodium level. The inclusion of serum sodium was a modification to the original MELD score to improve its predictive accuracy for mortality in patients with end-stage liver disease. This modified score is known as the MELD-Na score.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Serum albumin level:</span></strong><span style=\"font-size:12.0pt\"> Serum albumin level is not included in the MELD score calculation, although it is an important parameter in assessing liver function and nutritional status.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Platelet count:</span></strong><span style=\"font-size:12.0pt\"> Platelet count is not part of the MELD score calculation but is often used in assessing the degree of portal hypertension and hypersplenism in liver disease patients.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Hemoglobin level:</span></strong><span style=\"font-size:12.0pt\">&nbsp; Hemoglobin level is also not included in the MELD score calculation and is not directly related to liver function, although anemia can be a complication of end-stage liver disease.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Serum sodium level, in addition to serum bilirubin, serum creatinine, and INR, is essential for calculating the MELD score, which is used to assess the severity and prognosis of end-stage liver disease for transplantation prioritization.</span></span></span></p>",
      "correct_choice_id": 81074,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "CriteriaBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 20279,
      "choices": [
        {
          "id": 81077,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Tuberculous peritonitis</span></span></span></p>"
        },
        {
          "id": 81078,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Cirrhosis</span></span></span></p>"
        },
        {
          "id": 81079,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Pancreatic ascites</span></span></span></p>"
        },
        {
          "id": 81080,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Nephrotic syndrome</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 60-year-old man with a history of alcohol use disorder presents with new-onset ascites. Paracentesis is performed, and the serum-ascites albumin gradient (SAAG) is calculated to be 1.8 g/dL. Which of the following is the most likely cause of his ascites?</span></span></p>",
      "unique_key": "Q3261845",
      "question_audio": null,
      "question_video": null,
      "map_id": 30753,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. B) Cirrhosis</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">A serum-ascites albumin gradient (SAAG) of 1.8 g/dL is indicative of portal hypertension, with a value equal to or greater than 1.1 g/dL being highly suggestive of this condition. Cirrhosis, particularly in the context of a history of alcohol use disorder, is a common cause of portal hypertension and therefore a likely cause of ascites in this patient.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><u><span style=\"font-size:12.0pt\">&nbsp;<strong>Explanation:</strong></span></u></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Tuberculous peritonitis:</span></strong><span style=\"font-size:12.0pt\"> Tuberculous peritonitis typically presents with a low SAAG, suggesting that the ascites is not due to portal hypertension but to peritoneal inflammation.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Pancreatic ascites:</span></strong><span style=\"font-size:12.0pt\">&nbsp; Pancreatic ascites is usually due to leakage of pancreatic enzymes causing inflammation and ascites with a low SAAG, indicating that the cause is not related to portal hypertension.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Nephrotic syndrome:</span></strong><span style=\"font-size:12.0pt\"> Nephrotic syndrome can cause ascites due to hypoalbuminemia leading to reduced oncotic pressure, but it typically results in a low SAAG, as the ascites is not due to portal hypertension.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">A high serum-ascites albumin gradient (SAAG) of 1.1 g/dL or greater is indicative of portal hypertension, with cirrhosis being a common cause, especially in patients with a history of alcohol use disorder.</span></span></span></p>",
      "correct_choice_id": 81078,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "InvestigationBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 20280,
      "choices": [
        {
          "id": 81081,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Budd-Chiari syndrome </span></span></span></p>"
        },
        {
          "id": 81082,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Congestive heart failure </span></span></span></p>"
        },
        {
          "id": 81083,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Malignant ascites </span></span></span></p>"
        },
        {
          "id": 81084,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Hepatic venous outflow obstruction</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">A 45-year-old female with no significant medical history presents with abdominal swelling and discomfort. A diagnostic paracentesis shows a SAAG of 0.9 g/dL. Which of the following conditions is most likely associated with her ascites? </span></span></span></p>",
      "unique_key": "Q5824983",
      "question_audio": null,
      "question_video": null,
      "map_id": 30754,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. </span></strong><strong><span style=\"font-size:12.0pt\">C) Malignant ascites</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C: </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">A serum-ascites albumin gradient (SAAG) lower than 1.1 g/dL suggests that the ascites is not due to portal hypertension. In this case, the most likely cause of ascites with a SAAG of 0.9 g/dL is malignant ascites, which is caused by the direct spread of malignancy in the peritoneal cavity, leading to fluid accumulation due to cancer-related inflammation and changes in vascular permeability.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Options A. Budd-Chiari syndrome and D. Hepatic venous outflow obstruction</span></strong><span style=\"font-size:12.0pt\">: Both typically lead to portal hypertension and would more likely present with a SAAG greater than 1.1 g/dL.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Congestive heart failure:</span></strong><span style=\"font-size:12.0pt\"> Can cause ascites due to increased hydrostatic pressure in the systemic and portal venous systems, typically resulting in a SAAG greater than 1.1 g/dL, indicating that the ascites is due to portal hypertension secondary to heart failure.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">A SAAG lower than 1.1 g/dL suggests the ascites is not due to portal hypertension and that malignant ascites is caused by the direct spread of cancer in the peritoneal cavity.</span></span></span></p>",
      "correct_choice_id": 81083,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 20281,
      "choices": [
        {
          "id": 81085,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Peritoneal carcinomatosis </span></span></span></p>"
        },
        {
          "id": 81086,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Alcoholic cirrhosis </span></span></span></p>"
        },
        {
          "id": 81087,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Congestive heart failure </span></span></span></p>"
        },
        {
          "id": 81088,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Pancreatic ascites</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 50-year-old male with a history of chronic heart failure presents with progressive abdominal distension. Paracentesis reveals a SAAG of 1.3 g/dL. Which of the following is the most likely cause of his ascites? </span></span></p>",
      "unique_key": "Q9337468",
      "question_audio": null,
      "question_video": null,
      "map_id": 30755,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. </span></strong><strong><span style=\"font-size:12.0pt\">C) Congestive heart failure</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">A serum-ascites albumin gradient (SAAG) of 1.3 g/dL indicates portal hypertension as the likely underlying mechanism of ascites. In the context of a patient with a history of chronic heart failure, the ascites is most likely due to congestive heart failure. This condition can lead to increased venous pressure, including portal hypertension, resulting in the transudative type of ascites reflected by a high SAAG.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Peritoneal carcinomatosis:</span></strong><span style=\"font-size:12.0pt\"> Peritoneal carcinomatosis typically leads to exudative ascites with a low SAAG, as the ascites formation is due to peritoneal involvement by malignant cells rather than portal hypertension.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Alcoholic cirrhosis:</span></strong><span style=\"font-size:12.0pt\"> Alcoholic cirrhosis could also present with a high SAAG due to portal hypertension; however, the patient&#39;s history of chronic heart failure makes congestive heart failure a more likely cause in this case.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Pancreatic ascites:</span></strong><span style=\"font-size:12.0pt\"> Pancreatic ascites usually results from the leakage of pancreatic enzymes, leading to inflammation and exudative ascites with a low SAAG, not related to portal hypertension.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">A high SAAG (&ge;1.1 g/dL) in a patient with chronic heart failure is indicative of ascites due to congestive heart failure, reflecting portal hypertension secondary to increased venous pressure.</span></span></span></p>",
      "correct_choice_id": 81087,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 20282,
      "choices": [
        {
          "id": 81089,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Increase the dose of his current diuretic</span></span></span></p>"
        },
        {
          "id": 81090,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Start antibiotic prophylaxis</span></span></span></p>"
        },
        {
          "id": 81091,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Perform a large-volume paracentesis</span></span></span></p>"
        },
        {
          "id": 81092,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Restrict dietary sodium</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 55-year-old man with a history of cirrhosis due to chronic hepatitis C infection presents with new-onset ascites. What is the most appropriate initial step in the management of his ascites?</span></span></p>",
      "unique_key": "Q5348893",
      "question_audio": null,
      "question_video": null,
      "map_id": 30756,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. D) Restrict dietary sodium</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Dietary sodium restriction is a cornerstone in the initial management of ascites, particularly in cirrhotic patients, to help reduce fluid accumulation. This approach, often in conjunction with diuretic therapy, aims to decrease sodium and water retention.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Increase the dose of his current diuretic:</span></strong><span style=\"font-size:12.0pt\"> Increasing the dose of his current diuretic without first attempting dietary modifications may lead to electrolyte imbalances and kidney injury.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Start antibiotic prophylaxis:</span></strong><span style=\"font-size:12.0pt\"> Antibiotic prophylaxis is indicated in specific situations, such as prior episodes of spontaneous bacterial peritonitis (SBP), but not as an initial step for all cases of ascites.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Perform a large-volume paracentesis:</span></strong><span style=\"font-size:12.0pt\">&nbsp; Large-volume paracentesis is typically reserved for tense ascites causing respiratory discomfort or as a diagnostic procedure.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational Objective:</span></u></strong><u> </u></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Dietary sodium restriction is the initial management strategy for patients with cirrhosis presenting with ascites.</span></span></span></p>",
      "correct_choice_id": 81092,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 20298,
      "choices": [
        {
          "id": 81153,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\">Grade I</span></span></span></p>"
        },
        {
          "id": 81154,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\">Grade II</span></span></span></p>"
        },
        {
          "id": 81155,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\">Grade III</span></span></span></p>"
        },
        {
          "id": 81156,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\">Grade IV</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 55-year-old woman with cirrhosis is evaluated in the clinic. She is oriented to person, place, and time but demonstrates poor concentration and mild confusion about recent events. She has no asterixis or other focal neurological signs. According to the West Haven Criteria, how would her hepatic encephalopathy be graded?</span></span></p>",
      "unique_key": "Q2397629",
      "question_audio": null,
      "question_video": null,
      "map_id": 30764,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. A) Grade I</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">According to the West Haven Criteria for grading hepatic encephalopathy, Grade I is characterized by mild confusion, euphoria or depression, decreased attention, and a slight change in personality or behavior. The patient&#39;s symptoms of poor concentration and mild confusion about recent events, without asterixis or other focal neurological signs, fit the description of Grade I hepatic encephalopathy.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Grade II: </span></strong><span style=\"font-size:12.0pt\">Hepatic encephalopathy is characterized by increased confusion, disorientation to time, obvious personality changes, inappropriate behavior, and asterixis (flapping tremor).</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Grade III:</span></strong><span style=\"font-size:12.0pt\"> Involves a somnolent but arousable state, profound confusion, disorientation to time and place, and more pronounced asterixis.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Grade IV: </span></strong><span style=\"font-size:12.0pt\">Is characterized by coma with or without response to painful stimuli.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Grade I is characterized by mild confusion and poor concentration without more severe neurological signs.</span></span></span></p>",
      "correct_choice_id": 81153,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "CriteriaBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 20299,
      "choices": [
        {
          "id": 81157,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Oral lactulose</span></span></span></p>"
        },
        {
          "id": 81158,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Intravenous albumin</span></span></span></p>"
        },
        {
          "id": 81159,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Oral propranolol</span></span></span></p>"
        },
        {
          "id": 81160,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">High-dose vitamin K</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following is the most appropriate long-term treatment to prevent further episodes of hepatic encephalopathy in a patient with advanced cirrhosis?</span></span></p>",
      "unique_key": "Q4199557",
      "question_audio": null,
      "question_video": null,
      "map_id": 30765,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. A) Oral lactulose</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Oral lactulose is the most appropriate long-term treatment for preventing recurrent episodes of hepatic encephalopathy in a patient with advanced cirrhosis. Lactulose is a non-absorbable disaccharide that works by acidifying the colonic contents, leading to the conversion of ammonia to ammonium, which is not absorbed, thereby reducing blood ammonia levels and preventing episodes of hepatic encephalopathy.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Intravenous albumin:</span></strong><span style=\"font-size:12.0pt\"> Intravenous albumin is used in the management of patients with cirrhosis and complications such as spontaneous bacterial peritonitis or hepatorenal syndrome, but it is not a standard treatment for preventing hepatic encephalopathy.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Oral propranolol:</span></strong><span style=\"font-size:12.0pt\"> Oral propranolol is used for primary prophylaxis of variceal bleeding in cirrhotic patients by reducing portal hypertension, not for preventing hepatic encephalopathy.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. High-dose vitamin K:</span></strong><span style=\"font-size:12.0pt\"> High-dose vitamin K is sometimes used in cirrhotic patients to correct coagulopathy, but it does not play a role in the prevention of hepatic encephalopathy.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Oral lactulose is the most appropriate long-term treatment for preventing recurrent episodes of hepatic encephalopathy in patients with advanced cirrhosis, due to its mechanism of reducing blood ammonia levels.</span></span></span></p>",
      "correct_choice_id": 81157,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 20300,
      "choices": [
        {
          "id": 81161,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"IT\" style=\"font-size:12.0pt\">Renal cell carcinoma </span></span></span></p>"
        },
        {
          "id": 81162,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"IT\" style=\"font-size:12.0pt\">Hepatocellular carcinoma (HCC) </span></span></span></p>"
        },
        {
          "id": 81163,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"IT\" style=\"font-size:12.0pt\">Pancreatic adenocarcinoma </span></span></span></p>"
        },
        {
          "id": 81164,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"IT\" style=\"font-size:12.0pt\">Colorectal adenocarcinoma</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 60-year-old man with a history of alcohol abuse and chronic hepatitis B infection is found to have an elevated alpha-fetoprotein (AFP) level during routine screening making him vulnerable for ?&nbsp; </span></span></p>",
      "unique_key": "Q1130734",
      "question_audio": null,
      "question_video": null,
      "map_id": 30766,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\">Ans. </span></strong><strong><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\">B) Hepatocellular carcinoma (HCC)</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B: </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">A history of alcohol abuse and chronic hepatitis B infection are significant risk factors for the development of hepatocellular carcinoma (HCC). An elevated alpha-fetoprotein (AFP) level is often used as a biomarker in the screening and diagnosis of HCC, making this condition the most likely given the patient&#39;s background and laboratory findings.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Renal cell carcinoma:</span></strong><span style=\"font-size:12.0pt\">&nbsp; Renal cell carcinoma is not typically associated with alcohol abuse, hepatitis B infection, or elevated AFP levels.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Pancreatic adenocarcinoma:</span></strong><span style=\"font-size:12.0pt\"> Pancreatic adenocarcinoma is also not directly linked to alcohol abuse, hepatitis B infection, or elevated AFP levels as specific risk factors or biomarkers.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Colorectal adenocarcinoma:</span></strong><span style=\"font-size:12.0pt\"> Colorectal adenocarcinoma, while alcohol consumption may be a risk factor, is not directly associated with hepatitis B infection or elevated AFP levels as a specific biomarker.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Alcohol abuse and chronic hepatitis B infection, combined with an elevated alpha-fetoprotein (AFP) level, significantly increases the likelihood of developing hepatocellular carcinoma (HCC).</span></span></span></p>",
      "correct_choice_id": 81162,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "InvestigationBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 20301,
      "choices": [
        {
          "id": 81165,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"IT\" style=\"font-size:12.0pt\">Hypoglycemia</span></span></span></p>"
        },
        {
          "id": 81166,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"IT\" style=\"font-size:12.0pt\">Elevated alpha-fetoprotein (AFP)</span></span></span></p>"
        },
        {
          "id": 81167,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"IT\" style=\"font-size:12.0pt\">Hyponatremia</span></span></span></p>"
        },
        {
          "id": 81168,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"IT\" style=\"font-size:12.0pt\">Hypoalbuminemia</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 62-year-old woman with a history of non-alcoholic steatohepatitis (NASH) presents with worsening fatigue and abdominal distension. An abdominal ultrasound reveals a nodular liver and ascites. Which additional finding would most suggest the presence of hepatocellular carcinoma (HCC)?</span></span></p>",
      "unique_key": "Q2944307",
      "question_audio": null,
      "question_video": null,
      "map_id": 30767,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. B) Elevated alpha-fetoprotein (AFP)</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Elevated alpha-fetoprotein (AFP) is a tumor marker often associated with hepatocellular carcinoma (HCC). In the context of a patient with risk factors for liver cancer, such as non-alcoholic steatohepatitis (NASH) and findings suggestive of cirrhosis (nodular liver and ascites), an elevated AFP would further suggest the presence of HCC.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Hypoglycemia:</span></strong><span style=\"font-size:12.0pt\"> Hypoglycemia can occur in advanced liver disease due to the liver&#39;s impaired gluconeogenesis, but it is not specific for HCC.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Hyponatremia:</span></strong><span style=\"font-size:12.0pt\"> Hyponatremia is common in advanced liver disease, particularly with the development of ascites and portal hypertension, but it is not specific for HCC.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Hypoalbuminemia:</span></strong><span style=\"font-size:12.0pt\"> Hypoalbuminemia is indicative of liver dysfunction and is a common feature of cirrhosis and advanced liver disease but does not specifically suggest HCC.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">An elevated alpha-fetoprotein (AFP) level, particularly in a patient with risk factors and liver disease such as NASH, is suggestive of hepatocellular carcinoma (HCC).</span></span></span></p>",
      "correct_choice_id": 81166,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "InvestigationBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 20302,
      "choices": [
        {
          "id": 81169,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Early arterial enhancement with washout in the venous phase</span></span></span></p>"
        },
        {
          "id": 81170,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Continuous enhancement in both arterial and venous phases</span></span></span></p>"
        },
        {
          "id": 81171,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Lack of enhancement in all phases</span></span></span></p>"
        },
        {
          "id": 81172,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Late venous enhancement without arterial enhancement</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which imaging characteristic on contrast-enhanced computed tomography (CECT) is most indicative of hepatocellular carcinoma (HCC)?</span></span></p>",
      "unique_key": "Q8926135",
      "question_audio": null,
      "question_video": null,
      "map_id": 30768,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. A) Early arterial enhancement with washout in the venous phase</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The most characteristic imaging feature of hepatocellular carcinoma (HCC) on contrast-enhanced computed tomography (CECT) is early arterial enhancement followed by washout in the portal venous or delayed phases. This pattern reflects the tumor&#39;s arterial vascular supply and the rapid washout of contrast, distinguishing HCC from the surrounding liver parenchyma, which is predominantly supplied by the portal vein.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Explanation:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Continuous enhancement in both arterial and venous phases:</span></strong><span style=\"font-size:12.0pt\"> It&nbsp; is not typical for HCC and may suggest other types of lesions or benign vascular processes.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Lack of enhancement in all phases:</span></strong><span style=\"font-size:12.0pt\"> It is not characteristic of HCC. HCC typically shows some degree of contrast enhancement due to its arterial supply.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Late venous enhancement without arterial enhancement:</span></strong><span style=\"font-size:12.0pt\"> It is not a typical feature of HCC and may be seen in other types of liver lesions or vascular abnormalities.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Early arterial enhancement with washout in the venous phase on contrast-enhanced computed tomography (CECT) is a key imaging characteristic indicative of hepatocellular carcinoma (HCC) in patients with liver disease, such as cirrhosis due to chronic hepatitis C.</span></span></span></p>",
      "correct_choice_id": 81169,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 20303,
      "choices": [
        {
          "id": 81173,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Systemic chemotherapy</span></span></span></p>"
        },
        {
          "id": 81174,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Liver transplantation</span></span></span></p>"
        },
        {
          "id": 81175,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Radiofrequency ablation (RFA)</span></span></span></p>"
        },
        {
          "id": 81176,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Palliative care</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">What is the most appropriate first-line treatment option for early-stage hepatocellular carcinoma (HCC) and well-preserved liver function?</span></span></p>",
      "unique_key": "Q8768888",
      "question_audio": null,
      "question_video": null,
      "map_id": 30769,
      "difficulty_level": "difficult",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. C) Radiofrequency ablation (RFA)</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C: </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">For a patient with early-stage hepatocellular carcinoma (HCC) and well-preserved liver function, radiofrequency ablation (RFA) is an appropriate first-line treatment option. RFA is minimally invasive and effective for small tumors, offering good outcomes for patients with early-stage disease and preserved liver function.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Systemic chemotherapy:</span></strong><span style=\"font-size:12.0pt\"> Systemic chemotherapy is generally not the first-line treatment for early-stage HCC due to its limited efficacy and potential for systemic side effects.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Liver transplantation:</span></strong><span style=\"font-size:12.0pt\"> Liver transplantation is a potential treatment option for early-stage HCC, especially for patients with underlying cirrhosis and liver dysfunction. However, it is typically considered when other curative treatments like resection or ablation are not feasible or have failed, and the patient meets specific criteria (such as the Milan criteria).</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Palliative care:</span></strong><span style=\"font-size:12.0pt\"> Palliative care is an important aspect of managing advanced cancer but is not the appropriate first-line treatment for a patient with early-stage HCC and well-preserved liver function, who has potentially curative treatment options.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Radiofrequency ablation (RFA) is an appropriate first-line treatment for patients with early-stage hepatocellular carcinoma (HCC) and well-preserved liver function, offering a minimally invasive approach with the potential for curative outcomes.</span></span></span></p>",
      "correct_choice_id": 81175,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    }
  ]
}